(Reuters) – The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the U.S. should be lifted and use of the vaccine should resume, the FDA said on Friday.
(Reporting by Kanishka Singh in Bengaluru; Editing by Chris Reese)
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Herro scores 24, Heat hit franchise playoff-record 23 3s to beat Boston and even series 1-1
Shohei Ohtani has 3 doubles, Landon Knack get 1st victory as Dodgers rout Nationals 11-2
Cubs reliever Luke Little forced to change his glove because of white in American flag patch
Minnesota’s Naz Reid wins NBA’s Sixth Man of the Year award, edging Malik Monk in close vote
A high-profile murder trial in Kazakhstan boosts awareness of domestic violence
Venice launches experiment to charge day-trippers an access fee in bid to combat over-tourism
US growth likely slowed last quarter but still pointed to a solid economy
Columbia’s president, no stranger to complex challenges, walks tightrope on student protests
Blinken, in Shanghai, begins expected contentious talks with Chinese officials
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US abortion battle rages on with moves to repeal Arizona ban and a Supreme Court case
US births fell last year, marking an end to the late pandemic rebound, experts say
